Michael W. Triplett - Feb 23, 2022 Form 4 Insider Report for Cigna Corp (CI)

Role
President, U.S. Commercial
Signature
By: Jill M. Stadelman, attorney-in-fact
Stock symbol
CI
Transactions as of
Feb 23, 2022
Transactions value $
$0
Form type
4
Date filed
2/25/2022, 07:49 PM
Previous filing
Jun 16, 2021
Next filing
Mar 1, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +2.66K +11.21% $0.00 26.4K Feb 23, 2022 Direct F1
holding CI Common Stock, $.01 Par Value 7.77K Feb 23, 2022 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +11.9K $0.00 11.9K Feb 23, 2022 Common Stock, $.01 Par Value 11.9K $227.02 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted shares vest in three equal annual installments beginning March 1, 2023.
F2 Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
F3 This option vests in three equal annual installments beginning March 1, 2023.